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S U M M A R Y
Background: Human parechovirus type 1 (HPeV-1) appears to be associated with gastrointestinal and
respiratory infections, and occasionally with central nervous system symptoms. Since there is no
accurate information about the incidence and epidemiology of HPeV-1 in Iran, this study was designed to
describe the frequency of HPeV-1 in stool samples from children under 4 years of age with
gastroenteritis.
Methods: RNA was isolated from stool suspensions and cDNA was prepared and ampliﬁed using a
speciﬁc nested reverse transcription PCR (RT-PCR). We also compared this RT-PCR method with a cell
culture procedure.
Results: Out of 472 samples, 112 (23.7%) were HPeV-1-positive. The incidence and prevalence of this
virus was highest in children under 1 year old with diarrhea (p = 0.036), and was higher in the spring and
autumn than in summer and winter (p < 0.001). More males than females were HPeV-1-positive
(p < 0.001).
Conclusions: This is the ﬁrst systematic study of the incidence and epidemiology of HPeV-1 among
children with acute gastroenteritis in Iran. The results revealed that RT-PCR is a more practical, sensitive,
and rapid technique for the detection of HPeV-1 directly from clinical samples than cell culture, which
makes this a valuable method for epidemiology. Also, the rapid detection of virus can decrease both the
unnecessary use of antibiotics and costs in clinical practice.
 2012 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Parechoviruses are small, non-enveloped, positive-sense, sin-
gle-stranded RNA (ssRNA) viruses in the Parechovirus genus within
the large family of Picornaviridae, which is a highly diverse family
of important pathogens of humans and animals. The Parechovirus
genus was deﬁned in the early 1990s.1,2 The genus is composed of
two species: Ljungan virus, isolated from bank voles,3 and human
parechovirus (HPeV), a frequent human pathogen. The prototype
strains, HPeV types 1 and 2, were previously classiﬁed as echovirus
types 22 and 23 within the Enterovirus genus, but were later (1999)
renamed and reclassiﬁed as HPeV genotype 1 (HPeV-1) and HPeV
genotype 2 (HPeV-2) on the basis of their distinctive biological and
molecular properties.1,4,5 HPeV-1 and HPeV-2 were ﬁrst isolated
during a summer outbreak of diarrhea in children in 1956.6 The
genome of HPeV has an average length of 7300 nucleotides and is
packaged into an icosahedral capsid made up of multiple copies of
each of the capsid proteins VP0, VP3, and VP1.1,7* Corresponding author. Tel./fax: +98 21 88602209.
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http://dx.doi.org/10.1016/j.ijid.2012.05.1020HPeV-1 infections are prevalent worldwide and have generally
been associated with gastrointestinal and respiratory infections,8–
10 and occasional cases of central nervous system (CNS)
infections.11 A recent study in Japan reported that 63 out of 110
cases (57.3%) were HPeV-1-positive using a reverse transcription
PCR (RT-PCR) method. Among the 63 patients who were positive
for HPeV-1, 35 (55.6%) were diagnosed with gastroenteritis and 11
(17.5%) with a respiratory illness.12 HPeV-1 did not seem to be
involved in CNS infections.
Previous ﬁndings have revealed the genetic variability of HPeVs,
and the number of newly identiﬁed HPeV genotypes has been on the
increase. On the basis of VP1 sequence comparisons, 14 HPeV types
have been described to date.12–18 HPeV infection is commonly
observed in the general population; at least 95% of the adult
population is seropositive for HPeV-1-speciﬁc antibodies.19,20 It has
been shown that HPeV infections are often acquired in early
childhood, with 20% of children being infected after the ﬁrst year of
life.20 In another study, the frequencies of HPeV were shown to vary
substantially over the study period, with a high rate of HPeV-1
detection in late summer and early winter, restricted to children
aged between 6 months and 5 years.8 As is the case for the
enteroviruses, the gold standard procedure for the diagnosis ofternational Society for Infectious Diseases.
Table 1
Primers used in this study and their positions
Primer name Primer sequence Position
F1 50 ATA GTG AGA TAC CAC GC TTG 30 232–252
R1 50 GGG ATC CCT GGT TTC C-T -T- T 30 622–644
F2 50 TCA CAC AGC CAT CCT CTA GT 30 267–278
R2 50ACG GGT ACC TTC TGG GCA TC30 512–532
ENT-F 50 CAA GCC TTC TGT TTC CCC GG 30 100–180
ENT-R 50 ATT GTC ACC ATA AGC AGC CA30 580–599
Figure 1. Detection of human parechovirus type 1 RNA by nested PCR with two sets
of primers from the 50 untranslated region. Lane M: molecular weight marker; lane
1: ﬁrst round PCR product (412 bp); lane 2: negative control; lanes 3 and 4: negative
cases; lane 5: positive control; lanes 6–11: positive cases after second round PCR
(265 bp).
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procedure is time-consuming and may lack sensitivity. Several
former studies have improved the sensitivity of HPeV-1 detection
from the stool specimens of children by using epidemiological
information. More recent studies have suggested using genetic data
rather than seroreactivity for the detection of HPeV.18,21
A rapid, sensitive, and speciﬁc genome detection by RT-PCR has
recently been developed for the detection of enterovirus. Due to
sequence differences with enteroviruses,1 HPeV-1 is not detected
with these assays and requires speciﬁc RT-PCR procedures. Since
there have been no reports on HPeV-1 infection in Iran, the present
study aimed to use a sensitive and speciﬁc nested RT-PCR
ampliﬁcation method with highly conserved primers to screen
stool samples collected from Iranian children with diarrhea for
HPeV-1 infection. This assay provides the starting point for the
investigation of a potential epidemiological study and can be
applied directly to clinical specimens rather than to cultured virus.
2. Materials and methods
2.1. Clinical specimens
Four hundred and seventy-two stool specimens were collected
from Iranian children under 4 years of age with diarrhea who were
being treated as outpatients. Stool samples analyzed in this study
were collected from September 2007 through December 2009 and
stored at 20 8C until analysis (without additives). To inactivate
RNase, all microtubes and tips were treated with diethylpyr-
ocarbonate (DEPC; 1%) overnight and then autoclaved.
Written consent was obtained from all subjects participating in
this study.
2.2. Preparation of fecal suspension
The fecal specimens were diluted with distilled water to 10%
(w/v) suspension and were clariﬁed by centrifugation at 10 000 g
for 15 min. Supernatants were then stored at 20 8C until used.
2.3. RNA extraction and cDNA synthesis
RNA was extracted from the fecal suspension using a QIAamp
Viral RNA Mini Kit (Qiagen Inc., Germany) in accordance with the
manufacturer’s instructions. Extracted RNA was stored at 80 8C.
A nested RT-PCR method was used for HPeV-1 screening. RNA
from individual samples was reverse transcribed into cDNA by the
use of a reverse transcription system (Fermentas cDNA Synthesis
Kit). Brieﬂy, 10 ml of the extracted RNA, 1 ml oligo dT (100 mM),
and 1 ml Fermentas cDNA synthesis water were mixed and
incubated at 65 8C for 5 min, then chilled on ice. Subsequently,
4 ml 5 ﬁrst strand buffer, 1 ml Ribo Lock RNase inhibitor (20 U/
ml), 2 ml dNTPs mix (10 mM), and 1 ml Revert Aid M-Mul-V reverse
transcriptase (200 U/ml) were added to give a total volume of
20 ml. The reaction mixture was incubated at 42 8C for 60 min,
followed by incubation at 70 8C for an additional 5 min, and then
placed on ice. cDNA was either used directly for PCR or stored at
20 8C for less than a week or stored frozen at 80 8C for longer
periods of time prior to PCR analysis.
2.4. Primer design and nested RT-PCR
Two sets of speciﬁc primers (Table 1) were designed by
sequence alignment according to the 50 untranslated region
(50UTR) of HPeV-1 Harris strain; the nucleotide sequences were
obtained from GenBank (accession number L02971). There was no
cross-match between these primers and the genome of other
viruses according to NCBI nucleotide BLAST. The speciﬁcity of theHPeV-1 RT-PCR was conﬁrmed using enterovirus general primers
(ENT-F and ENT-R) (Table 1).22
2.5. First round PCR reaction and cycling program
Brieﬂy, 3 ml of cDNA was mixed with Qiagen PCR master mix
(2 reaction buffer, 200 mM of each dNTPs, 4 mM MgCl2), 0.5 mM
of each primer (F1 and R1), 0.05 U/ml Taq DNA polymerase, and
nuclease free water to a ﬁnal volume of 25 ml. The cycling program
was as follows: 95 8C for 5 min, followed by 35 cycles of 95 8C for
1 min, 57 8C for 1 min, and 72 8C for 1.5 min, with a ﬁnal extension
at 72 8C for 5 min. The PCR products were separated by 1.5%
agarose gel electrophoresis and visualized under ultraviolet light
after ethidium bromide staining (Figure 1).
2.6. Second round PCR reaction
One microliter of ﬁrst round PCR product was used as the
template and ampliﬁed using the same procedures (cycling
parameters), except the annealing step which was performed at
55 8C (Figure 1). The speciﬁcity of the assay was conﬁrmed by
testing 20 parechovirus RT-PCR-positive cDNA samples with
enterovirus general primers (Table 1). None of these samples
were positive with the enterovirus PCR assay. In order to compare
the RT-PCR method with the cell culture procedure, 20 RT-PCR-
positive samples were also inoculated in Vero cell cultures for virus
isolation and were examined daily for the appearance of cytopathic
effect (CPE). Each PCR product was puriﬁed using the Min Elute Gel
Extraction Kit (Qiagen) and directly sequenced (Analyser IIX and
HiSeq 2000, USA) from both sides using HPeV-1 ampliﬁcation
primers to conﬁrm HPeV-1 genome fragments.
Table 2
Characteristics of cases
Variable Number of
cases
Positive
cases, n (%)
Negative
cases, n (%)
472 112 (23.7%) 360 (76.3%)
Sex
Male 190 67 (35.3%) 123 (64.7%)
Female 282 45 (16.0%) 237 (84.0%)
Age
<6 months 264 55 (20.8%) 209 (79.2%)
6–12 months 146 46 (31.5%) 100 (68.5%)
>12–24 months 38 9 (23.7%) 29 (76.3%)
>24–48 months 24 2 (8.3%) 22 (91.7%)
Seasons
Spring 100 34 (34%) 66 (66%)
Summer 84 12 (14.3%) 72 (85.7%)
Autumn 172 58 (33.7%) 114 (66.3%)
Winter 116 8 (6.9%) 108 (93.1%)
Figure 2. Age distribution. The highest prevalence of human parechovirus type 1
was in children under 1 year of age, with a major peak in those aged 6–12 months
(p = 0.036).
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3. Results and discussion
Human parechoviruses, members of the Parechovirus genus of
the family Picornaviridae, are single-stranded, positive-sense RNA
viruses that cause a spectrum of diseases similar to that of the
human enteroviruses, including gastroenteritis, respiratory dis-
eases, aseptic meningitis, encephalitis, and neonatal sepsis-like
disease.16,23,24 Recent studies in other countries have shown HPeV-
1 to be the predominant HPeV genotype found in children with
acute gastroenteritis,8,24,25 and more than a half of the strains
detected have been HPeV-1.14,23,24,26,27 In general, HPeV-1 appears
to be responsible for a higher rate of gastrointestinal syndrome and
is often associated with watery diarrhea in children.19,23
Previously, HPeVs were identiﬁed by neutralization assay
following virus isolation in cell culture, using a panel of antisera.
However, HPeVs often grow poorly in culture, typing reagents are
not widely available, and the technique is laborious, time-
consuming, and may lack sensitivity. Increasing knowledge of
the molecular biology of the genome has led to the development of
a number of RT-PCR-based assays that enable the rapid and speciﬁc
detection of small amounts of viral nucleic acids in clinical
specimens.12,14,19,28,29
Due to genetic differences, even within the conserved 50-
noncoding region,1,5,13,30 most molecular techniques designed for
the detection of enteroviruses cannot detect HPeVs.29,30 Hence in
this study, 472 stool samples from children under 4 years of age
with diarrhea were tested for HPeV-1 by speciﬁc nested RT-PCR
method using highly conserved primers from the 50UTR of the
HPeV-1 Harrison strain (accession number L02971) genome
sequence available from the GenBank database. RNA was extracted
from stool suspensions and cDNA was prepared and ampliﬁed. A
previous study has reported that the 50UTR assay is more sensitive
than VP1 RT-PCR. The 50UTR primer set allowed the detection of 0.4
TCID50 (median tissue culture infective dose)/25 ml of virus
compared to 40 TCID50/25 ml with the VP1 primer set.
29 After
two sets of 50UTR primers were developed, a two-step nested RT-
PCR was used for the detection of HPeV-1. The PCR product was
separated by agarose gel electrophoresis and visualized under UV
after staining with ethidium bromide. The predicted ﬁnal size was
265 bp (Figure 1).
The speciﬁcity of the HPeV-1 RT-PCR was conﬁrmed using
enterovirus general primers (Table 1).22 For comparing the RT-PCR
method with the gold standard cell culture procedure for the
detection of HPeV-1, 20 HPeV-1-positive samples were cultured in
Vero cells; only six of them were found to be CPE-positive after 3
weeks. It was recognized for the ﬁrst time that echovirus 22–HPeV-
1 shows a slow and atypical CPE.8,19
In order to conﬁrm the HPeV-1 genome, 20 PCR products were
sequenced from both sides and compared with HPeV-1 sequences
obtained from the GenBank database. All positive isolates were
most closely related to the HPeV-1 reference strain and
were negative when we used an enterovirus-speciﬁc assay. This
result showed that the HPeV-1 RT-PCR was speciﬁc. Viral genomic
sequences should also be useful for the identiﬁcation of genotypes.
They also provide essential information for the determination of
speciﬁc molecular target sequences for virus identiﬁcation.
Among 472 samples collected during the 2-year study period,
112 (23.7%) were found to be HPeV-1-positive (Table 2). The
prevalence of this virus was highest in children under 1 year old,
peaking at between 6 and 12 months of age (p = 0.036) (Table 2,
Figure 2). The absence of any detectable HPeV infections in older
children is consistent with previous seroepidemiological studies,
which have documented a 72% seroprevalence of antibodies toHPeV-1 by the age of 2 years, reaching 99% in adulthood.20
Seroepidemiological studies in Japan and Finland suggest that
children are infected with HPeVs early in life, reaching a high
cumulative rate of seropositivity by the time they enter primary
school.19,31 Several features of seasonal and sex distribution are
concordant with previous investigations of the epidemiology of
HPeV-1.8,9 With regard to the seasonal distribution of HPeV-1,
most was found during the early autumn (October and November)
and spring (March and April) (p < 0.001), with a low distribution in
summer (July to September) and winter (December to February)
(Table 2). Similar to a previous study,27 more males than females
were HPeV-1-positive (p < 0.001) (Table 2).
The present study demonstrates that HPeV-1 infection is
associated with diarrhea. In addition, with a detection rate of 112
among the 472 samples tested (23.7%), the study shows that HPeV-
1-related diarrhea is not rare in Iran.
In conclusion, to our knowledge, this is the ﬁrst report of HPeV-
1 infections among infants and children with diarrhea in Iran. The
present study suggests that HPeV-1 is not rare in Iran and should
be included in the spectrum of viruses for which children with
diarrhea are routinely screened. The results of this study conﬁrm
that the RT-PCR method is a more practical, rapid, and sensitive
technique for detecting virus directly from clinical samples than
cell culture, which makes this a valuable method for epidemiology.
Also, the rapid diagnosis of virus can decrease both the
unnecessary use of antibiotics and the costs of clinical treatment.
F. Ghazi et al. / International Journal of Infectious Diseases 16 (2012) e673–e676e676Further research is needed to identify genotypes and to clarify the
prevalence and etiological importance of each serotype of HPeV in
the general population.
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